Episode 254: 254. Empagliflozin For Heart Failure with Preserved Ejection Fraction- EMPEROR-Preserved

Hospitalization for heart failure occurred in 8.6% of patients in the empagliflozin group and 11.8% patients in the placebo group (hazard ratio, 0.71; 95% CI, 0.60 to 0.83)number needed to treat [NNT] = 32 per 26 months But the drug company did a great job of writting the paper so you think there is mortality benefithttps://www.nejm.org/doi/full/10.1056/NEJMoa2107038